Team and Partners

A Multidisciplinary Team with a Global Vision

VIVA In Vitro Diagnostics has a highly skilled team that combines scientific excellence, business execution and disruptive purpose. 

Our management team, scientific team, partners and advisory board are committed to innovation in biomedical diagnostics and personalised medicine. 

Viva In Vitro Diagnostics Equipo Completo

Team 

Experts transforming science into cutting-edge diagnostic solutions.

Our team combines technical depth, translational insight and regulatory rigour to develop tools that make a difference in clinical practice. 

Toni Vilaplana Vivancos

CEO & Miembro del Consejo de Administración

MBA por el IESE y abogado. Más de 25 años como directivo senior en grandes compañías, así como gestión de equipos, y con más de 10 años de experiencia como consultor en operaciones de M&A y reestructuraciones.

Dra. Verónica Cánovas

Biotechnological Development Manager

PhD in Biochemistry, Molecular Biology and Biomedicine from the Autonomous University of Barcelona. Experience leading biomedical research in institutions such as Vall d’Hebron. She has been responsible for national and European biotechnology projects.  

Pablo González Polanco

Quality Assurance & Regulatory Affairs Manager

MSc in Biomedical Engineering (Marquette University), with extensive 510(k) experience before the FDA. From Massachusetts General Hospital, where developed microfluidic systems, he also led Quality and Regulatory Affairs in the design of a diagnostic system for coagulopathies. 

María Carmen Baños Gregori

Laboratory Management (Biotechnological Development Dept.)

More than 10 years of experience in Molecular Biology and Microbiology laboratories at IMIB and at the Faculty of Life Sciences of the University of Manchester. Postgraduate in Cell Culture and Animal Experimentation, Master in Clinical Trials. 

Carmen Mendoza Moreno

Research and Development Assistant

She has a degree in Biotechnology and a master’s degree in Bioinformatics. She has extensive experience in the field of research and biomolecular diagnostics.

Rocio Baños Martínez

Laboratory Management Assistant

Rocio’s contribution as a biomedical clinical laboratory technician is part of our growth as a company, which leads us to incorporate young talent with a strong commitment to our mission. 

Alicia Blázquez

Responsable Administración

Nuestra responsable de Administración nos aporta la experiencia de más de 25 años trabajando para PYMES, empresas de alto crecimiento y compañías del sector biotecnológico, así como la gestión de departamentos de recursos humanos, gestión de finanzas y relaciones con la administración pública.

Juan Carlos Milena

Marketing & PR

Expert in corporate communication for corporations, startups and open innovation ecosystems, he offers us the necessary connection with national and international media, as well as direct actions with our audiences.  

Ecosystem for clinical validation 

Strategic partnerships to bring laboratory innovation to hospital practice.

Validating solutions in real-world environments requires collaboration with the best. Our clinical network combines multidisciplinary expertise, certified infrastructures and access to critical populations. 

Dr. Ricard Ferrer Roca

PI in ongoing trials

Head of the Intensive Care Department at Hospital Universitari Vall d’Hebron (Barcelona) and leader of the SODIR research group.

logo_VH_Master_

Dr. Gerardo Aguilar Aguilar

PI in ongoing trials

Head of the Critical Care Unit, Department of Anesthesiology and Resuscitation, Hospital Clínic Universitari de València.

Piedad-Martinez

Dra. Piedad Martínez Gil

PI in ongoing trials

Specialist in the Anaesthesia and Resuscitation Department at Hospital Universitario Virgen de la Arrixaca (Murcia). 

v

Dra. Elena Giráldez Vázquez

PI in ongoing trials

Specialist in Intensive Care Medicine at Hospital Universitario Virgen de la Victoria de Málaga (Málaga) 

Dra. María Antonia Estecha

CO-PI in ongoing trials

Head of the Intensive Care Medicine Service at the Virgen de la Victoria University Hospital.

Strategic Partnerships and Collaborations  

Thanks to the collaboration of: 

Strategic Partnerships and Collaborations  

Our company is at the centre of an ecosystem of alliances where institutions and companies of the highest prestige converge. From patners to accelerate market access to strong institutional backing.  

Medical Advisory Board

We are pleased to announce the first collaborations with external advisors joining our advisory board.

Thanks to their insight, they provide strategic, technical, and scientific support. They are top-level clinical specialists with direct experience in intensive care medicine, infectious diseases, and hospital diagnostics. 

Dr. Ricard Ferrer Roca

External Advisor (Lead Coordinator)

External Advisor (Coordinator) of the Medical Advisory Board of Viva In Vitro. Head of the Intensive Care Department at Hospital Universitari Vall d’Hebron (Barcelona) and leader of the SODIR research group. Former President of SEMICYUC, former Treasurer and President of the SIS Section of ESICM, member of the Board of the World Federation of Societies of Intensive Care and trustee of the Código Sepsis Foundation.

ignacio-martin-loeches

Prof. Ignacio Martín-Loeches

External Advisor

External Advisor to the Medical Advisory Board. He has an outstanding professional and academic track record in intensive care medicine, severe infections and sepsis. He is Professor at Trinity College Dublin and Consultant in Intensive Care Medicine at St James’s Hospital, a leading reference hospital in Europe. He combines extensive clinical experience, academic leadership and strong research activity.

International Scientific Advisory Committee 

Leading the revolution in inflammasome research with a global vision.

Coordinated by Dr. Pablo Pelegrín, our committee brings together the brightest minds in translational immunology to guide our developments with cutting-edge scientific rigour.  

Dr.-Mihai-Netea

Dr. Mihai Netea

Radboud University Medical Center, The Netherlands

Head of the Division of Experimental Medicine at the Department of Internal Medicine at Radboud UMC, and one of the most cited authors in immunology. Specialist in infectious diseases and innate immunity to pathogens. 

Dr.-Eduardo-López-Collazo

Dr. Eduardo López Collazo

Hospital Universitario de la Paz, Spain

Deputy Scientific Director of Health Research at the Hospital Universitario de la Paz and academic at the Latin American Academy of Sciences. His research interests include sepsis, cancer, leukaemia, cystic fibrosis, HIV and COVID-19. 

Dra.-Rebecca-Coll

Dra. Rebecca Coll

Queen's University Belfast, UK

Leader in the study of inflammasomes and their role in inflammatory diseases. She has led the biological characterisation of MCC950, an inhibitor of the NLRP3 inflammasome, with an impact on diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis and atherosclerosis.  

Founders and Council

Dr. Pablo Pelegrín Vivancos

Asesor Científico para el Comité de Dirección y Fundador

Deputy Scientific Director at IMIB and Professor of Immunology at the University of Murcia. Responsible for seminal contributions in this field, with international recognition for his research on inflammasomes and immune response.

Dr.-Carlos-García-Palenciano

Dr. Carlos García Palenciano

External Clinical Advisor and Founder of Viva In Vitro Diagnostics

Clinical Director. Head of the Department of Anesthesiology and Resuscitation at Hospital Universitario Virgen de la Arrixaca (Murcia).

Joaquín Gómez Moya

Asesor, Presidente del Consejo de Administración (no ejecutivo) y Fundador

More than 30 years of experience in corporate leadership, including companies in the bio- and nanotechnology sectors in Europe and the United States, as well as in the healthcare and DeepTech industries.

Toni Vilaplana Vivancos

Member of the Board of Directors (Secretary)

Rafael Crespo Carretero

Member of the Board of Directors.

Entrepreneur and investor with a strong focus on high-impact initiatives in healthcare, agribusiness and food. Representative of a solid investment group that has supported Viva In Vitro and its team since its inception.

More than €6m investment to fight sepsis

Thanks to the investors, family offices and institutions that have given us their support. Among them Rafael Crespo, who is part of our Board of Directors, together with Joaquín Gómez Moya and Toni Vilaplana. In our newly created Advisory Board, we have Enrique Riquelme and Guillermo Forner, together with Murcia Emprende. They have been joined by prestigious investors such as Antonio Ruiz Ballesta, Fran Rodríguez and Antonio Soria. 

Cutting-edge science. Working together towards the same goal.

Where cutting-edge science meets impeccable performance to save lives.

Because connecting scientific discoveries with patient care requires more than knowledge, it requires passion to transform the impossible into accessible treatments. 

It takes a unique combination of excellence and talent to bring scientific discoveries to the patient’s bedside through viable and scalable clinical solutions. 

A Multidisciplinary Team with a Global Vision

Our team brings together professionals with exceptional backgrounds in three key areas.  

  • GLOBAL SCIENTIFIC LEADERSHIP 

Pioneering researchers in NLRP3 inflammasomes and immunological biomarkers, with publications in the most prestigious journals in the field. 

  • BUSINESS MANAGEMENT EXPERIENCE 

Executives with proven track records in biomedical business management, international business development and high-value operations in cutting-edge markets. 

  • TECHNICAL AND CLINICAL KNOWLEDGE 

Specialists in biomedical developments, clinical trials, market access always firmly focused on the practical needs of the frontline of septic patient care.